A recent longitudinal observational study showed an increase in prevalence of maternal depression and anxiety among mothers in a Canadian cohort during the coronavirus disease 2019 (COVID-19) pandemic, between May 2020 and July 2020, compared with pre-pandemic estimates between April 2012 and October 2019.
Compared with older adults without serious medical illness (SMI), the prevalence and incidence of dementia diagnoses are markedly increased among those with schizophrenia across a wide age range, possibly because of cognitive and functional deterioration related to schizophrenia or factors contributing to other types of dementia, results of a recent study have shown.
New drug applications approved by US FDA as of 01-15 March 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
The investigational attention-deficit/hyperactivity disorder (ADHD) medication viloxazine extended-release, known as SPN-812, rapidly reduces symptoms in school-aged children with a tolerable safety profile, as shown in the results of a phase III trial.
A layperson-delivered, empathy-oriented telephone call programme reduces loneliness, depression and anxiety compared with no calls, and improves general mental health of the participants within 4 weeks, results of a randomized trial have shown.
Results of the world’s first randomized controlled study of a 4-week brief insomnia prevention programme for at-risk adolescents show a 71 percent reduction in the risk of developing insomnia, investigators from the Chinese University of Hong Kong (CUHK) have reported.
While major eating disorders share common genetic psychiatric risk, the genetics of body weight regulation may predispose a person to develop a particular eating disorder over others, according to a new study.
Paramedics suffer from considerable psychological discomfort when implementing prehospital termination of resuscitations (TOR), according to a recent Singapore study, and even structured training seems unable to combat this distress.
While early-phase clinical trials may demonstrate substantial levels of overall response rates in patients with relapsed/refractory multiple myeloma (RRMM), high heterogeneity of evidence prevents the accurate assessment of clinical benefit before patient participation, reports a recent meta-analysis.
The COVID-19 vaccine AZD1222 by AstraZeneca and the University of Oxford was 79 percent effective overall in preventing symptomatic infections – higher than observed in previous clinical trials of the vaccine – at the interim analysis of a US phase III trial.
Migraine and headache are common ailments of people living in the modern era. Dr Jon Marshall of The Singapore Headache and Migraine Clinic shares his insights with Pearl Toh on how to manage migraine and headache using non-pharmaceutical strategies, with a focus on the manual medicine approach.